Related Experiment Video
Updated: Jun 10, 2026

Human Circadian Phenotyping and Diurnal Performance Testing in the Real World
Published on: April 7, 2020
Rest-activity disturbances in children with septo-optic dysplasia characterized by actigraphy and 24-hour plasma
E A Webb1, M A O'Reilly, J Orgill
1University College London (UCL) Institute of Child Health, Great Ormond Street Children's Hospital, London, United Kingdom. e.webb@ich.ucl.ac.uk
Insights
Melatonin secretion varies greatly in children with septo-optic dysplasia (SOD), and objective sleep/activity patterns are often disrupted. This study found no clear evidence of common sleep disorders, highlighting the need for individualized management strategies.
Area of Science:
- Pediatric Endocrinology
- Sleep Medicine
- Neurodevelopmental Disorders
Background:
- Melatonin treatment is common for sleep issues in children with septo-optic dysplasia (SOD).
- Objective sleep/activity data and 24-hour melatonin profiles are lacking for this population.
- The pathophysiology of sleep disorders in SOD remains poorly understood.
Purpose of the Study:
- To objectively assess sleep/activity patterns and 24-hour melatonin profiles in children with SOD and sleep disruption.
- To investigate the relationship between melatonin secretion and sleep disturbances in SOD.
- To explore potential underlying sleep disorders in this cohort.
Main Methods:
- Six children with SOD and rest-activity disturbances were studied.
- Actigraphy (Actiwatch-Mini) was used for 2 weeks to monitor movement and sleep.
- Hourly serum melatonin levels were measured over a 24-hour period in a hospital setting.
Main Results:
- Two children had undetectable melatonin and fragmented sleep, without non-24-hour or delayed sleep-phase disorder.
- One child exhibited an arrhythmic sleep pattern despite a normal melatonin profile.
- Three children had fragmented sleep; two had normal melatonin profiles, and one had altered daytime melatonin levels.
Conclusions:
- Significant variability exists in melatonin secretion timing and levels among children with SOD.
- No participants showed objective evidence of non-24-hour or delayed sleep-phase disorders.
- Recognizing the diverse nature of sleep disorders in SOD is crucial for effective patient management.
Introduction:
A trial of melatonin treatment in children with septo-optic dysplasia (SOD) and sleep disruption is accepted clinical practice in many centers. However, no objective measurements of sleep/activity patterns with 24-h melatonin profiles have been published for these individuals, and the pathophysiological basis underlying sleep disorders in SOD remains largely unknown.
Methods:
We studied six children with rest-activity disturbances and SOD. All wore an Actiwatch-Mini (a noninvasive method of detecting and recording movement intensity) for 2 wk and were admitted to hospital for a 24-h period during which hourly measurements of serum melatonin were taken. Sleep data were analyzed in conjunction with a detailed sleep diary. Ethical approval was obtained for these studies.
Results:
Two children produced virtually no melatonin throughout the 24-h period of measurement and had fragmented sleep patterns with no evidence of a non-24-h sleep-wake disorder or delayed sleep-phase disorder. One child had a normal melatonin profile despite actigraphy showing an arrhythmic sleep pattern. The remaining three children had fragmented sleep, with two having normal melatonin profiles and one having a modest increase in daytime melatonin concentrations, making the timing of dim-light melatonin onset difficult to discern.
Conclusions:
There is considerable variation in timing and amount of melatonin secretion in these children. Surprisingly, none of the children had either actigraphic or melatonin profile evidence of a non-24-h sleep-wake disorder or delayed sleep-phase disorder. Understanding the heterogeneous nature of underlying sleep disorders in this group of children is important and has implications for their management.
Related Concept Videos
REM Sleep Behavior Disorder
RBD is significantly associated with...
Management of Insomnia
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Nightmares and Night Terrors
Nightmares often...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

